FAQs
Is ZION a buy sell or hold? ›
Zions Bancorporation, National Association has received a consensus rating of Hold. The company's average rating score is 2.24, and is based on 5 buy ratings, 11 hold ratings, and 1 sell rating.
What is the price prediction for Zions? ›Stock Price Forecast
The 19 analysts offering 12-month price forecasts for Zions Bancorporation NA have a median target of 37.00, with a high estimate of 45.00 and a low estimate of 27.00. The median estimate represents a +4.79% increase from the last price of 35.31.
What do analysts say about Zions Bancorporation National Association? Zions Bancorporation National Association's analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
What's going on with Zions Bank? ›Zions and other banks are recovering from a turbulent start to the year. Stocks tanked in March after two big banks failed, and Moody's Investment Services downgraded Zions Bancorps in April, making it harder for the bank to borrow money.
Should I hold or sell Zim stock? ›ZIM Integrated Shipping Services Ltd (ZIM) stock is lower by -59.65% over the last 12 months, and the average rating from Wall Street analysts is a Hold.
Why is ZION oil stock falling? ›(ZN 0.30%) stock is falling on Wednesday and was down more than 16% at 10:45 a.m. EST. That sell-off is mainly due to profit-taking after shares in the Israel-focused oil driller skyrocketed yesterday when it announced that it struck oil while drilling in the country.
What is the key stock forecast for 2025? ›KeyCorp Stock Prediction 2025
The KeyCorp stock prediction for 2025 is currently $ 13.50, assuming that KeyCorp shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 20.83% increase in the KEY stock price.
Year | Yearly Low | Yearly High |
---|---|---|
2025 | $ 0.030903 | $ 0.125025 |
2026 | $ 0.034395 | $ 0.057109 |
2027 | $ 0.036105 | $ 0.089771 |
2028 | $ 0.078868 | $ 0.089094 |
What is the Bancor Network Token price prediction for 2023? Bancor Network Token is forecasted to trade within a range of $ 0.342534 and $ 1.046904. If it reaches the upper price target, BNT could increase by 162.89% and reach $ 1.046904.
What is the strongest buy stock? ›Company (Ticker) | Forward P/E Ratio |
---|---|
Datadog (DDOG) | 60.1 |
Dexcom (DXCM) | 62.3 |
Fortive (FTV) | 20.8 |
Lamb Weston (LW) | 16.3 |
Does ZION Oil and Gas pay dividends? ›
Cash dividends will be paid on all shares held outside of your DSPP account. Dividends on shares held inside of your DSPP account will be reinvested fully.
Should I buy Rocket Pharmaceuticals stock? ›Rocket Pharmaceuticals's analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
Why is Zions Bank being downgraded? ›Zions has “significant” unrealized losses on its securities portfolio and its capital has deteriorated, Moody's said. The ratings firm's focus on unrealized losses misses the “tremendous value” of Zions's granular, low-cost deposit base, said James Abbott, the bank's director of investor relations.
Who is the largest shareholder of Zions Bank? ›Top Shareholders
The Vanguard Group, Inc. BlackRock, Inc. State Street Global Advisors, Inc.
The main competitors of Zions Bancorporation, National Association include BOK Financial (BOKF), Cullen/Frost Bankers (CFR), First Horizon (FHN), Old National Bancorp (ONB), F.N.B. (FNB), UMB Financial (UMBF), BancFirst (BANF), Community Bank System (CBU), Simmons First National (SFNC), and Fulton Financial (FULT).
Should I hold or sell Lcid? ›Lucid Group's analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts. How can I buy shares of LCID?
Should I buy or sell Lcid? ›The consensus among 8 Wall Street analysts covering (NASDAQ: LCID) stock is to Hold LCID stock.
What is the stock price prediction for Rocket Pharmaceuticals? ›Rocket Pharmaceuticals Inc (NASDAQ:RCKT)
The 9 analysts offering 12-month price forecasts for Rocket Pharmaceuticals Inc have a median target of 48.00, with a high estimate of 65.00 and a low estimate of 39.00. The median estimate represents a +107.08% increase from the last price of 23.18.
Rocket Lab USA's analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.